Human Psychopharmacology-Clinical and Experimental

Papers
(The H4-Index of Human Psychopharmacology-Clinical and Experimental is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Effects of lasmiditan on simulated driving performance: Results of two randomized, blinded, crossover studies with placebo and active controls30
A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans18
N,N‐dimethyltryptamine and Amazonian ayahuasca plant medicine16
Psilocybin occasioned mystical‐type experiences16
The effect of cannabidiol on simulated car driving performance: A randomised, double‐blind, placebo‐controlled, crossover, dose‐ranging clinical trial protocol14
Efficacy of amisulpride for depressive symptoms in individuals with mental disorders: A systematic review and meta‐analysis14
Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment‐resistant depression13
Gabapentinoids for treatment of alcohol use disorder: A systematic review and meta‐analysis11
Anabolic androgenic steroids used as performance and image enhancing drugs in professional and amateur athletes: Toxicological and psychopathological findings11
Alpha7 nicotinic‐N‐methyl‐D‐aspartate hypothesis in the treatment of schizophrenia and beyond11
Comparison of potential psychiatric drug interactions in six drug interaction database programs: A replication study after 2 years of updates11
0.050784111022949